Trial intelligence / Profile preview

Bioequivalence of generic itopride hydrochloride 50 mg vs Ganaton in healthy Thai volunteers under fasting

TCTR20241012004Phase 2Completed

Sponsor
MacroPhar
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of mosapride, itopride, sponsored by MacroPhar. Started Nov 2024; status: completed.

02

Drugs

mosaprideitopride

Beyond the preview

Go deeper on TCTR20241012004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20241012004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call